I want to request testing by your laboratory, what do I have to do for this?

You will need to contact your doctor. Please tell your doctor to visit our website and to download our test kit order form (USA or outside USA), fill and sign it and submit it to our office together with a copy of his/her medical license. After that we will send a test kit to your doctor’s office.

I am a doctor and it is the first time I am going to send you samples. Should I send you my medical license?

Yes, please submit a copy of your medical license to our office by fax or e-mail.

The instruction sheet for Nagalase says to stop immune stimulants prior to testing. However, these are part of the treatment for the patient. Will these immune stimulants affect the result if they are not stopped for testing?

The immune stimulants decrease the Nagalase activity. We advise to draw blood for the Nagalase test just before the immune stimulant medication is given. If this medication is given once a week, as is mostly the case, then this will pose no problem. However, if a one week interval is not possible: at least try to use the same time period each time to have the best follow up.

The instruction sheet for the Methylation Pathway Panel says to stop medication (if possible) prior to testing. What kind of medication should be discontinued and for what time?

It would be better to stop intake of vitamin B6 and B12 for 48 hours before the blood draw since the high intake of these vitamins may affect the results.

Publications – Health Diagnostics and Research Institute

2023

Kirby J., Adams J. , Trahan S., Audhya T., Musavi A., Kennedy S., and Alexander A. R. Vitamin D and Covid-19. Natural Medicine Journal. Aug 2023

https://www.naturalmedicinejournal.com/journal/vitamin-d-and-covid-19

2022

Musavi A, and Audhya T. Conventional Use of LC/MSMS in Clinical Diagnostics: Present Status. Townsend Letter 462 : 364:48-50, 2022.

2013

Audhya T, Pall ML, Green JA. A study of sauna therapy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients shows sauna action via raised tetrahydrobiopterin and confirms three predictions of the NO/ONOO-Cycle. Townsend Letter (Nov), 364:60-64, 2013.
McGinnis WR, Audhya T, Edelson SM. Proposed toxic and hypoxic impairment of a brainstem locus in Autism. Intl J Environmental Research and Public Health, 10(12):6955-7000, 2013.
Adams JB, Audhya T, McDonough-Means et al. Toxicological status of children with autism vs. neurotypical children and the association with autism severity. Biological Trace Element Research, 151(2):171-80, 2013.

2012

Bradstreet JJ, Vogelaar E, Thyer L. Initial observations on elevated alpha-N-acetylgalactosaminidase activity associated with Autism and observed reductions from GC protein-macrophage activating factor injections. Autism Insights, 4:31-38, 2012.
Audhya T, Adams JB, Johansen L. Correlation of serotonin levels in CSF, platelets, plasma, and urine. Biochim Biophys Acta, 1820:1496-501, 2012.
Kern JK, Geier DA, Audhya T et al. Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiologiae Experimentalis, 72(2):113-152, 2012.
Chauhan A, Audhya T, Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochemical Research, 37(8):1681-9, 2012.
Bradstreet JJ, Vogelaar E, Thyer L. Initial observations of elevated alpha-N-acetylgalactosaminidase activity associated with autism and observed reductions from GC protein-macrophage activating factor injections. Autism Insights, 4:31-38, 2012.

2011

Adams J, Audhya T, McDonough. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatrics, 11:111, 2011.
Adams J, Audhya T, McDonough. Nutritional and metabolic status of children with autism vs. neurotypical children and the asociation with autism severity. Nutrition and Metabolism, 8:34, 2011.
Freedenfeld S et al. Biochemical effects of ribose and NADH therapy in children with autism. Autism Insights, 3:3-13, 2011.
Kern JK, Geier DA, Adams JB et al. A clinical trial of glutathione supplementation in autism spectrum disorders. Medical Science Monitor, 17:CR677-682, 2011.